English

Fibrocell Science, Inc.

EDGAR

FCSC Quarterly report (10-Q) · filed 2019-11-14

128 filing records in this dataset, filed from 1996-11-04 to 2019-11-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2019 Q1 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-3.1 million USD

2019 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -3100000 USD Source

Free cash flow

-3.11 million USD

2019 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -3100000 USD Source
Capital Expenditure: 9000 USD Source

Cash and cash equivalents: 6.8 million USD 2019-09-30 Source
Exact value

6800000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 9.76 million shares 2019-09-30 Source
Exact value

9758332 shares

Reported share-count change

4.76% · 443 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

9314982 shares · 2018-09-30· Source
9758332 shares · 2019-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2018-04-01 – 2019-03-31

Exact inputs and evidence

Revenue: 0 USD · 2018-04-01 – 2018-06-30 Source
Revenue: 0 USD · 2018-07-01 – 2018-09-30 Source
Revenue: 0 USD · 2018-01-01 – 2018-12-31 Source
Revenue: 0 USD · 2018-01-01 – 2018-09-30 Source
Revenue: 0 USD · 2019-01-01 – 2019-03-31 Source

Operating cash flow

-9.77 million USD

2018-10-01 – 2019-09-30

Exact inputs and evidence

Operating cash flow: -12700000 USD · 2018-01-01 – 2018-12-31 Source
Operating cash flow: -10217000 USD · 2018-01-01 – 2018-09-30 Source
Operating cash flow: -3100000 USD · 2019-01-01 – 2019-03-31 Source
Operating cash flow: -600000 USD · 2019-01-01 – 2019-06-30 Source
Operating cash flow: -3100000 USD · 2019-01-01 – 2019-03-31 Source
Operating cash flow: -7285000 USD · 2019-01-01 – 2019-09-30 Source
Operating cash flow: -600000 USD · 2019-01-01 – 2019-06-30 Source

Capital expenditure

349 thousand USD

2018-10-01 – 2019-09-30

Exact inputs and evidence

Capital expenditure: 164000 USD · 2018-01-01 – 2018-12-31 Source
Capital expenditure: 155000 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 9000 USD · 2019-01-01 – 2019-03-31 Source
Capital expenditure: 87000 USD · 2019-01-01 – 2019-06-30 Source
Capital expenditure: 9000 USD · 2019-01-01 – 2019-03-31 Source
Capital expenditure: 340000 USD · 2019-01-01 – 2019-09-30 Source
Capital expenditure: 87000 USD · 2019-01-01 – 2019-06-30 Source

Free cash flow

-10.1 million USD

2018-10-01 – 2019-09-30

Exact inputs and evidence

Operating cash flow: -12700000 USD · 2018-01-01 – 2018-12-31 Source
Operating cash flow: -10217000 USD · 2018-01-01 – 2018-09-30 Source
Operating cash flow: -3100000 USD · 2019-01-01 – 2019-03-31 Source
Operating cash flow: -600000 USD · 2019-01-01 – 2019-06-30 Source
Operating cash flow: -3100000 USD · 2019-01-01 – 2019-03-31 Source
Operating cash flow: -7285000 USD · 2019-01-01 – 2019-09-30 Source
Operating cash flow: -600000 USD · 2019-01-01 – 2019-06-30 Source
Capital expenditure: 164000 USD · 2018-01-01 – 2018-12-31 Source
Capital expenditure: 155000 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 9000 USD · 2019-01-01 – 2019-03-31 Source
Capital expenditure: 87000 USD · 2019-01-01 – 2019-06-30 Source
Capital expenditure: 9000 USD · 2019-01-01 – 2019-03-31 Source
Capital expenditure: 340000 USD · 2019-01-01 – 2019-09-30 Source
Capital expenditure: 87000 USD · 2019-01-01 – 2019-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2019-11-14.

Financial data available through: 2018-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2018-12-31
Operating income: 11 of 11 periods available· newest 2018-12-31
Net income: 11 of 11 periods available· newest 2018-12-31
Operating cash flow: 11 of 11 periods available· newest 2018-12-31
Capital expenditure: 11 of 11 periods available· newest 2018-12-31
Total assets: 9 of 11 periods available· newest 2018-12-31
Total liabilities: 9 of 11 periods available· newest 2018-12-31
Current assets: 9 of 11 periods available· newest 2018-12-31
Current liabilities: 9 of 11 periods available· newest 2018-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2018-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2018-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2017-01-01 – 2017-12-31
Current period

USD 0

2018-01-01 – 2018-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
0 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Fibrocell Science, Inc. · 2018-12-31 Fibrocell Science, Inc. (edgar:357097) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#349601 Filing: 000162828019003496 Input fundies:Revenue: 0 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#349465 Filing: 000162828019003496
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 5.94 million

Prior period

−USD 16.24 million

2017-01-01 – 2017-12-31
Current period

−USD 10.3 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

-10300000 − -16240000 = 5940000 USD

-16240000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
-10300000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Fibrocell Science, Inc. · 2018-12-31 Fibrocell Science, Inc. (edgar:357097) Year-over-year change in Net income: 5940000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -10300000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#327101 Filing: 000162828019003496 Input fundies:NetIncome: -16240000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#326570 Filing: 000162828019003496
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 4.34 million

Prior period

−USD 17.04 million

2017-01-01 – 2017-12-31
Current period

−USD 12.7 million

2018-01-01 – 2018-12-31

Exact inputs and evidence

-12700000 − -17037000 = 4337000 USD

-17037000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
-12700000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Fibrocell Science, Inc. · 2018-12-31 Fibrocell Science, Inc. (edgar:357097) Year-over-year change in Operating cash flow: 4337000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -12700000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#326358 Filing: 000162828019003496 Input fundies:OperatingCashFlow: -17037000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#325934 Filing: 000162828019003496
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-62.1%

Prior period

USD 433,000

2017-01-01 – 2017-12-31
Current period

USD 164,000

2018-01-01 – 2018-12-31

Exact inputs and evidence

164000 − 433000 = -269000 USD

433000 USD · 2017-01-01 – 2017-12-31
Inspect prior input Prior source
164000 USD · 2018-01-01 – 2018-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Fibrocell Science, Inc. · 2018-12-31 Fibrocell Science, Inc. (edgar:357097) Year-over-year change in Capital expenditure: -269000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 164000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#331096 Filing: 000162828019003496 Input fundies:CapitalExpenditure: 433000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#330887 Filing: 000162828019003496
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2018 2018-01-01 – 2018-12-31

Revenue USD 0
Operating costs Derived USD 12.39 million
Operating income −USD 12.39 million
Tax, interest and other Derived −USD 2.09 million
Net income −USD 10.3 million

Cash

Operating cash flow −USD 12.7 million
Capital expenditure USD 164,000
Free cash flow Derived −USD 12.86 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Operating loss: operating costs were 1,429% of revenue.
2010 Operating loss: operating costs were 1,335% of revenue.
2013 Operating loss: operating costs were 15,352% of revenue.
2014 Operating loss: operating costs were 16,741% of revenue.
2015 Operating loss: operating costs were 7,703% of revenue.
2016 Operating loss: operating costs were 7,559% of revenue.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	329941	4713600 Derived	-4383659	666340 Derived	-5049999	-4662880 Derived	Source 2009-01-01 – 2009-12-31: 329941 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -4383659 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -5049999 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -4662880 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	936369	12504548 Derived	-11568179	1363352 Derived	-12931531	-13594598 Derived	Source 2010-01-01 – 2010-12-31: 936369 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -11568179 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -12931531 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -13564924 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 29674 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	200000	30703000 Derived	-30503000	1051000 Derived	-31554000	-20435000 Derived	Source 2013-01-01 – 2013-12-31: 200000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -30503000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -31554000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -20075000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 360000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	180000	30134000 Derived	-29954000	-4304000 Derived	-25650000	-22538000 Derived	Source 2014-01-01 – 2014-12-31: 180000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -29954000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -25650000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -22296000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 242000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	492000	37899000 Derived	-37407000	-2954000 Derived	-34453000	-24377000 Derived	Source 2015-01-01 – 2015-12-31: 492000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -37407000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -34453000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -24106000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 271000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	355000	26834000 Derived	-26479000	-11187000 Derived	-15292000	-29643000 Derived	Source 2016-01-01 – 2016-12-31: 355000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -26479000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -15292000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -29390000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 253000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	0	18981000 Derived	-18981000	-2741000 Derived	-16240000	-17470000 Derived	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -18981000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -16240000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -17037000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 433000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	0	12389000 Derived	-12389000	-2089000 Derived	-10300000	-12864000 Derived	Source 2018-01-01 – 2018-12-31: 0 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -12389000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -10300000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -12700000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 164000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2018

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Revenue	1104885	Revenue: 1104885 Open source
20092009-08-31	Revenue	538620	Revenue: 538620 Open source
20092009-12-31	Revenue	329941	Revenue: 329941 Open source
20102010-12-31	Revenue	936369	Revenue: 936369 Open source
20132013-12-31	Revenue	200000	Revenue: 200000 Open source
20142014-12-31	Revenue	180000	Revenue: 180000 Open source
20152015-12-31	Revenue	492000	Revenue: 492000 Open source
20162016-12-31	Revenue	355000	Revenue: 355000 Open source
20172017-12-31	Revenue	0	Revenue: 0 Open source
20182018-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2017

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Year over year	No prior comparable period	Revenue: 1104885 Open source
20092009-08-31	Year over year	No prior comparable period	Revenue: 538620 Open source
20092009-12-31	Year over year	-70.1%	Revenue: 329941 Open source Revenue: 1104885 Open source
20102010-12-31	Year over year	183.8%	Revenue: 936369 Open source Revenue: 329941 Open source
20132013-12-31	Year over year	No prior comparable period	Revenue: 200000 Open source
20142014-12-31	Year over year	-10%	Revenue: 180000 Open source Revenue: 200000 Open source
20152015-12-31	Year over year	173.3%	Revenue: 492000 Open source Revenue: 180000 Open source
20162016-12-31	Year over year	-27.8%	Revenue: 355000 Open source Revenue: 492000 Open source
20172017-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 355000 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -7,458.9% 2016

Net margin -4,307.6% 2016

Free cash flow margin -8,350.1% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2008-12-31	Operating margin	Not reported	Revenue: 1104885 Open source
20092009-08-31	Operating margin	-1,006.4%	Operating Income: -5420611 Open source Revenue: 538620 Open source
20092009-12-31	Operating margin	-1,328.6%	Operating Income: -4383659 Open source Revenue: 329941 Open source
20102010-12-31	Operating margin	-1,235.4%	Operating Income: -11568179 Open source Revenue: 936369 Open source
20132013-12-31	Operating margin	-15,251.5%	Operating Income: -30503000 Open source Revenue: 200000 Open source
20142014-12-31	Operating margin	-16,641.1%	Operating Income: -29954000 Open source Revenue: 180000 Open source
20152015-12-31	Operating margin	-7,603%	Operating Income: -37407000 Open source Revenue: 492000 Open source
20162016-12-31	Operating margin	-7,458.9%	Operating Income: -26479000 Open source Revenue: 355000 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -18981000 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	Not reported	Operating Income: -12389000 Open source Revenue: 0 Open source
2008-12-31	Net margin	Not reported	Revenue: 1104885 Open source
20092009-08-31	Net margin	12,201.8%	Net Income: 65721531 Open source Revenue: 538620 Open source
20092009-12-31	Net margin	-1,530.6%	Net Income: -5049999 Open source Revenue: 329941 Open source
20102010-12-31	Net margin	-1,381%	Net Income: -12931531 Open source Revenue: 936369 Open source
20132013-12-31	Net margin	-15,777%	Net Income: -31554000 Open source Revenue: 200000 Open source
20142014-12-31	Net margin	-14,250%	Net Income: -25650000 Open source Revenue: 180000 Open source
20152015-12-31	Net margin	-7,002.6%	Net Income: -34453000 Open source Revenue: 492000 Open source
20162016-12-31	Net margin	-4,307.6%	Net Income: -15292000 Open source Revenue: 355000 Open source
20172017-12-31	Net margin	Not reported	Net Income: -16240000 Open source Revenue: 0 Open source
20182018-12-31	Net margin	Not reported	Net Income: -10300000 Open source Revenue: 0 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 1104885 Open source
20092009-08-31	Free cash flow margin	Not reported	Revenue: 538620 Open source
20092009-12-31	Free cash flow margin	-1,413.2%	Revenue: 329941 Open source Operating Cash Flow: -4662880 Open source Capital Expenditure: 0 Open source
20102010-12-31	Free cash flow margin	-1,451.8%	Revenue: 936369 Open source Operating Cash Flow: -13564924 Open source Capital Expenditure: 29674 Open source
20132013-12-31	Free cash flow margin	-10,217.5%	Revenue: 200000 Open source Operating Cash Flow: -20075000 Open source Capital Expenditure: 360000 Open source
20142014-12-31	Free cash flow margin	-12,521.1%	Revenue: 180000 Open source Operating Cash Flow: -22296000 Open source Capital Expenditure: 242000 Open source
20152015-12-31	Free cash flow margin	-4,954.7%	Revenue: 492000 Open source Operating Cash Flow: -24106000 Open source Capital Expenditure: 271000 Open source
20162016-12-31	Free cash flow margin	-8,350.1%	Revenue: 355000 Open source Operating Cash Flow: -29390000 Open source Capital Expenditure: 253000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -17037000 Open source Capital Expenditure: 433000 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -12700000 Open source Capital Expenditure: 164000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -12.7M 2018

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Operating cash flow	Not reported	No source recorded
20092009-08-31	Operating cash flow	Not reported	No source recorded
20092009-12-31	Operating cash flow	-4662880	Operating Cash Flow: -4662880 Open source
20102010-12-31	Operating cash flow	-13564924	Operating Cash Flow: -13564924 Open source
20132013-12-31	Operating cash flow	-20075000	Operating Cash Flow: -20075000 Open source
20142014-12-31	Operating cash flow	-22296000	Operating Cash Flow: -22296000 Open source
20152015-12-31	Operating cash flow	-24106000	Operating Cash Flow: -24106000 Open source
20162016-12-31	Operating cash flow	-29390000	Operating Cash Flow: -29390000 Open source
20172017-12-31	Operating cash flow	-17037000	Operating Cash Flow: -17037000 Open source
20182018-12-31	Operating cash flow	-12700000	Operating Cash Flow: -12700000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -12.9M 2018

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20082008-12-31	Free cash flow	Unavailable	No source recorded
20092009-08-31	Free cash flow	Unavailable	No source recorded
20092009-12-31	Free cash flow	-4662880	Operating Cash Flow: -4662880 Open source Capital Expenditure: 0 Open source
20102010-12-31	Free cash flow	-13594598	Operating Cash Flow: -13564924 Open source Capital Expenditure: 29674 Open source
20132013-12-31	Free cash flow	-20435000	Operating Cash Flow: -20075000 Open source Capital Expenditure: 360000 Open source
20142014-12-31	Free cash flow	-22538000	Operating Cash Flow: -22296000 Open source Capital Expenditure: 242000 Open source
20152015-12-31	Free cash flow	-24377000	Operating Cash Flow: -24106000 Open source Capital Expenditure: 271000 Open source
20162016-12-31	Free cash flow	-29643000	Operating Cash Flow: -29390000 Open source Capital Expenditure: 253000 Open source
20172017-12-31	Free cash flow	-17470000	Operating Cash Flow: -17037000 Open source Capital Expenditure: 433000 Open source
20182018-12-31	Free cash flow	-12864000	Operating Cash Flow: -12700000 Open source Capital Expenditure: 164000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

39.4% 2018

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Liabilities / assets	1,850.7%	Total Liabilities: 93524526 Open source Total Assets: 5053405 Open source
2009-08-31	Liabilities / assets	Not reported	No source recorded
20092009-12-31	Liabilities / assets	118.5%	Total Liabilities: 10341624 Open source Total Assets: 8724209 Open source
20102010-12-31	Liabilities / assets	269.2%	Total Liabilities: 22280883 Open source Total Assets: 8278145 Open source
20132013-12-31	Liabilities / assets	28%	Total Liabilities: 19348000 Open source Total Assets: 69014000 Open source
20142014-12-31	Liabilities / assets	33.4%	Total Liabilities: 15225000 Open source Total Assets: 45634000 Open source
20152015-12-31	Liabilities / assets	61.3%	Total Liabilities: 22509000 Open source Total Assets: 36712000 Open source
20162016-12-31	Liabilities / assets	59.9%	Total Liabilities: 11721000 Open source Total Assets: 19582000 Open source
20172017-12-31	Liabilities / assets	53.6%	Total Liabilities: 10404000 Open source Total Assets: 19411000 Open source
20182018-12-31	Liabilities / assets	39.4%	Total Liabilities: 6201000 Open source Total Assets: 15758000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.69× 2018

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20082008-12-31	Current assets / current liabilities	0.05×	Current Assets: 5053405 Open source Current Liabilities: 92352888 Open source
2009-08-31	Current assets / current liabilities	Not reported	No source recorded
20092009-12-31	Current assets / current liabilities	2.85×	Current Assets: 2383303 Open source Current Liabilities: 837078 Open source
20102010-12-31	Current assets / current liabilities	0.99×	Current Assets: 1915650 Open source Current Liabilities: 1942518 Open source
20132013-12-31	Current assets / current liabilities	17.22×	Current Assets: 61860000 Open source Current Liabilities: 3593000 Open source
20142014-12-31	Current assets / current liabilities	11.27×	Current Assets: 39349000 Open source Current Liabilities: 3493000 Open source
20152015-12-31	Current assets / current liabilities	2.02×	Current Assets: 30994000 Open source Current Liabilities: 15365000 Open source
20162016-12-31	Current assets / current liabilities	6.04×	Current Assets: 18028000 Open source Current Liabilities: 2987000 Open source
20172017-12-31	Current assets / current liabilities	4.05×	Current Assets: 17902000 Open source Current Liabilities: 4425000 Open source
20182018-12-31	Current assets / current liabilities	6.69×	Current Assets: 14535000 Open source Current Liabilities: 2172000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	−USD 5.05 million Exact value Exact value: -5049999 USD 2009-01-01 – 2009-12-31: -5049999 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fibrocell Science, Inc. · 2009-12-31 Fibrocell Science, Inc. (edgar:357097) Net Income: -5049999 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5049999 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/0000950123-11-030892.txt#8147 The citation records this snapshot. The page link may show a newer release later.	−USD 4.66 million Exact value Exact value: -4662880 USD 2009-01-01 – 2009-12-31: -4662880 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fibrocell Science, Inc. · 2009-12-31 Fibrocell Science, Inc. (edgar:357097) Operating Cash Flow: -4662880 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4662880 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/0000950123-11-030892.txt#26912 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fibrocell Science, Inc. · 2009-12-31 Fibrocell Science, Inc. (edgar:357097) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/0000950123-11-030892.txt#27003 The citation records this snapshot. The page link may show a newer release later.	−USD 4.66 million Calculation and evidence -4662880 − 0 USD Exact free cash flow: -4662880 USD 2009-01-01 – 2009-12-31: -4662880 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fibrocell Science, Inc. · 2009-12-31 Fibrocell Science, Inc. (edgar:357097) Free cash flow: -4662880 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4662880 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/0000950123-11-030892.txt#26912 Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/0000950123-11-030892.txt#27003 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 12.93 million Exact value Exact value: -12931531 USD 2010-01-01 – 2010-12-31: -12931531 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fibrocell Science, Inc. · 2010-12-31 Fibrocell Science, Inc. (edgar:357097) Net Income: -12931531 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12931531 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/0000950123-11-030892.txt#8147 The citation records this snapshot. The page link may show a newer release later.	−USD 13.56 million Exact value Exact value: -13564924 USD 2010-01-01 – 2010-12-31: -13564924 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fibrocell Science, Inc. · 2010-12-31 Fibrocell Science, Inc. (edgar:357097) Operating Cash Flow: -13564924 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13564924 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/0000950123-11-030892.txt#26912 The citation records this snapshot. The page link may show a newer release later.	USD 29,674 Exact value Exact value: 29674 USD 2010-01-01 – 2010-12-31: 29674 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fibrocell Science, Inc. · 2010-12-31 Fibrocell Science, Inc. (edgar:357097) Capital Expenditure: 29674 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29674 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/0000950123-11-030892.txt#27003 The citation records this snapshot. The page link may show a newer release later.	−USD 13.59 million Calculation and evidence -13564924 − 29674 USD Exact free cash flow: -13594598 USD 2010-01-01 – 2010-12-31: -13564924 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 29674 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fibrocell Science, Inc. · 2010-12-31 Fibrocell Science, Inc. (edgar:357097) Free cash flow: -13594598 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13564924 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/0000950123-11-030892.txt#26912 Input fundies:CapitalExpenditure: 29674 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/0000950123-11-030892.txt#27003 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 24.03 million Exact value Exact value: -24025000 USD 2011-01-01 – 2011-12-31: -24025000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fibrocell Science, Inc. · 2011-12-31 Fibrocell Science, Inc. (edgar:357097) Net Income: -24025000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24025000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000110465914043225/fcsc-20131231.xml#514054 Filing: 000110465914043225 The citation records this snapshot. The page link may show a newer release later.	−USD 16.84 million Exact value Exact value: -16837000 USD 2011-01-01 – 2011-12-31: -16837000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fibrocell Science, Inc. · 2011-12-31 Fibrocell Science, Inc. (edgar:357097) Operating Cash Flow: -16837000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16837000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000110465914043225/fcsc-20131231.xml#4892025 Filing: 000110465914043225 The citation records this snapshot. The page link may show a newer release later.	USD 1.57 million Exact value Exact value: 1570000 USD 2011-01-01 – 2011-12-31: 1570000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fibrocell Science, Inc. · 2011-12-31 Fibrocell Science, Inc. (edgar:357097) Capital Expenditure: 1570000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1570000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000110465914043225/fcsc-20131231.xml#571783 Filing: 000110465914043225 The citation records this snapshot. The page link may show a newer release later.	−USD 18.41 million Calculation and evidence -16837000 − 1570000 USD Exact free cash flow: -18407000 USD 2011-01-01 – 2011-12-31: -16837000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 1570000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fibrocell Science, Inc. · 2011-12-31 Fibrocell Science, Inc. (edgar:357097) Free cash flow: -18407000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16837000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000110465914043225/fcsc-20131231.xml#4892025 Filing: 000110465914043225 Input fundies:CapitalExpenditure: 1570000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000110465914043225/fcsc-20131231.xml#571783 Filing: 000110465914043225 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 12.69 million Exact value Exact value: -12687000 USD 2012-01-01 – 2012-12-31: -12687000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fibrocell Science, Inc. · 2012-12-31 Fibrocell Science, Inc. (edgar:357097) Net Income: -12687000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12687000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709715000016/fcsc-20141231.xml#247228 Filing: 000035709715000016 The citation records this snapshot. The page link may show a newer release later.	−USD 22.58 million Exact value Exact value: -22575000 USD 2012-01-01 – 2012-12-31: -22575000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fibrocell Science, Inc. · 2012-12-31 Fibrocell Science, Inc. (edgar:357097) Operating Cash Flow: -22575000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22575000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709715000016/fcsc-20141231.xml#246592 Filing: 000035709715000016 The citation records this snapshot. The page link may show a newer release later.	USD 493,000 Exact value Exact value: 493000 USD 2012-01-01 – 2012-12-31: 493000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fibrocell Science, Inc. · 2012-12-31 Fibrocell Science, Inc. (edgar:357097) Capital Expenditure: 493000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 493000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709715000016/fcsc-20141231.xml#259998 Filing: 000035709715000016 The citation records this snapshot. The page link may show a newer release later.	−USD 23.07 million Calculation and evidence -22575000 − 493000 USD Exact free cash flow: -23068000 USD 2012-01-01 – 2012-12-31: -22575000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 493000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fibrocell Science, Inc. · 2012-12-31 Fibrocell Science, Inc. (edgar:357097) Free cash flow: -23068000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22575000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709715000016/fcsc-20141231.xml#246592 Filing: 000035709715000016 Input fundies:CapitalExpenditure: 493000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709715000016/fcsc-20141231.xml#259998 Filing: 000035709715000016 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 31.55 million Exact value Exact value: -31554000 USD 2013-01-01 – 2013-12-31: -31554000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fibrocell Science, Inc. · 2013-12-31 Fibrocell Science, Inc. (edgar:357097) Net Income: -31554000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31554000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709716000133/fcsc-20151231.xml#231874 Filing: 000035709716000133 The citation records this snapshot. The page link may show a newer release later.	−USD 20.08 million Exact value Exact value: -20075000 USD 2013-01-01 – 2013-12-31: -20075000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fibrocell Science, Inc. · 2013-12-31 Fibrocell Science, Inc. (edgar:357097) Operating Cash Flow: -20075000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20075000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709716000133/fcsc-20151231.xml#231238 Filing: 000035709716000133 The citation records this snapshot. The page link may show a newer release later.	USD 360,000 Exact value Exact value: 360000 USD 2013-01-01 – 2013-12-31: 360000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fibrocell Science, Inc. · 2013-12-31 Fibrocell Science, Inc. (edgar:357097) Capital Expenditure: 360000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 360000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709716000133/fcsc-20151231.xml#240513 Filing: 000035709716000133 The citation records this snapshot. The page link may show a newer release later.	−USD 20.44 million Calculation and evidence -20075000 − 360000 USD Exact free cash flow: -20435000 USD 2013-01-01 – 2013-12-31: -20075000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 360000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fibrocell Science, Inc. · 2013-12-31 Fibrocell Science, Inc. (edgar:357097) Free cash flow: -20435000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20075000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709716000133/fcsc-20151231.xml#231238 Filing: 000035709716000133 Input fundies:CapitalExpenditure: 360000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709716000133/fcsc-20151231.xml#240513 Filing: 000035709716000133 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 25.65 million Exact value Exact value: -25650000 USD 2014-01-01 – 2014-12-31: -25650000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fibrocell Science, Inc. · 2014-12-31 Fibrocell Science, Inc. (edgar:357097) Net Income: -25650000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25650000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709716000133/fcsc-20151231.xml#232863 Filing: 000035709716000133 The citation records this snapshot. The page link may show a newer release later.	−USD 22.3 million Exact value Exact value: -22296000 USD 2014-01-01 – 2014-12-31: -22296000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fibrocell Science, Inc. · 2014-12-31 Fibrocell Science, Inc. (edgar:357097) Operating Cash Flow: -22296000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22296000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709716000133/fcsc-20151231.xml#231450 Filing: 000035709716000133 The citation records this snapshot. The page link may show a newer release later.	USD 242,000 Exact value Exact value: 242000 USD 2014-01-01 – 2014-12-31: 242000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fibrocell Science, Inc. · 2014-12-31 Fibrocell Science, Inc. (edgar:357097) Capital Expenditure: 242000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 242000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709716000133/fcsc-20151231.xml#240722 Filing: 000035709716000133 The citation records this snapshot. The page link may show a newer release later.	−USD 22.54 million Calculation and evidence -22296000 − 242000 USD Exact free cash flow: -22538000 USD 2014-01-01 – 2014-12-31: -22296000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 242000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fibrocell Science, Inc. · 2014-12-31 Fibrocell Science, Inc. (edgar:357097) Free cash flow: -22538000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22296000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709716000133/fcsc-20151231.xml#231450 Filing: 000035709716000133 Input fundies:CapitalExpenditure: 242000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709716000133/fcsc-20151231.xml#240722 Filing: 000035709716000133 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 34.45 million Exact value Exact value: -34453000 USD 2015-01-01 – 2015-12-31: -34453000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fibrocell Science, Inc. · 2015-12-31 Fibrocell Science, Inc. (edgar:357097) Net Income: -34453000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34453000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709717000033/fcsc-20161231.xml#218892 Filing: 000035709717000033 The citation records this snapshot. The page link may show a newer release later.	−USD 24.11 million Exact value Exact value: -24106000 USD 2015-01-01 – 2015-12-31: -24106000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fibrocell Science, Inc. · 2015-12-31 Fibrocell Science, Inc. (edgar:357097) Operating Cash Flow: -24106000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24106000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709717000033/fcsc-20161231.xml#218468 Filing: 000035709717000033 The citation records this snapshot. The page link may show a newer release later.	USD 271,000 Exact value Exact value: 271000 USD 2015-01-01 – 2015-12-31: 271000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fibrocell Science, Inc. · 2015-12-31 Fibrocell Science, Inc. (edgar:357097) Capital Expenditure: 271000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 271000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709717000033/fcsc-20161231.xml#223550 Filing: 000035709717000033 The citation records this snapshot. The page link may show a newer release later.	−USD 24.38 million Calculation and evidence -24106000 − 271000 USD Exact free cash flow: -24377000 USD 2015-01-01 – 2015-12-31: -24106000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 271000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fibrocell Science, Inc. · 2015-12-31 Fibrocell Science, Inc. (edgar:357097) Free cash flow: -24377000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24106000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709717000033/fcsc-20161231.xml#218468 Filing: 000035709717000033 Input fundies:CapitalExpenditure: 271000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000035709717000033/fcsc-20161231.xml#223550 Filing: 000035709717000033 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 15.29 million Exact value Exact value: -15292000 USD 2016-01-01 – 2016-12-31: -15292000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fibrocell Science, Inc. · 2016-12-31 Fibrocell Science, Inc. (edgar:357097) Net Income: -15292000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15292000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828018003348/fcsc-20171231.xml#261352 Filing: 000162828018003348 The citation records this snapshot. The page link may show a newer release later.	−USD 29.39 million Exact value Exact value: -29390000 USD 2016-01-01 – 2016-12-31: -29390000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fibrocell Science, Inc. · 2016-12-31 Fibrocell Science, Inc. (edgar:357097) Operating Cash Flow: -29390000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29390000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828018003348/fcsc-20171231.xml#260716 Filing: 000162828018003348 The citation records this snapshot. The page link may show a newer release later.	USD 253,000 Exact value Exact value: 253000 USD 2016-01-01 – 2016-12-31: 253000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fibrocell Science, Inc. · 2016-12-31 Fibrocell Science, Inc. (edgar:357097) Capital Expenditure: 253000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 253000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828018003348/fcsc-20171231.xml#266471 Filing: 000162828018003348 The citation records this snapshot. The page link may show a newer release later.	−USD 29.64 million Calculation and evidence -29390000 − 253000 USD Exact free cash flow: -29643000 USD 2016-01-01 – 2016-12-31: -29390000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 253000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fibrocell Science, Inc. · 2016-12-31 Fibrocell Science, Inc. (edgar:357097) Free cash flow: -29643000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29390000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828018003348/fcsc-20171231.xml#260716 Filing: 000162828018003348 Input fundies:CapitalExpenditure: 253000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828018003348/fcsc-20171231.xml#266471 Filing: 000162828018003348 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 16.24 million Exact value Exact value: -16240000 USD 2017-01-01 – 2017-12-31: -16240000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fibrocell Science, Inc. · 2017-12-31 Fibrocell Science, Inc. (edgar:357097) Net Income: -16240000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16240000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#326570 Filing: 000162828019003496 The citation records this snapshot. The page link may show a newer release later.	−USD 17.04 million Exact value Exact value: -17037000 USD 2017-01-01 – 2017-12-31: -17037000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fibrocell Science, Inc. · 2017-12-31 Fibrocell Science, Inc. (edgar:357097) Operating Cash Flow: -17037000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17037000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#325934 Filing: 000162828019003496 The citation records this snapshot. The page link may show a newer release later.	USD 433,000 Exact value Exact value: 433000 USD 2017-01-01 – 2017-12-31: 433000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fibrocell Science, Inc. · 2017-12-31 Fibrocell Science, Inc. (edgar:357097) Capital Expenditure: 433000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 433000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#330887 Filing: 000162828019003496 The citation records this snapshot. The page link may show a newer release later.	−USD 17.47 million Calculation and evidence -17037000 − 433000 USD Exact free cash flow: -17470000 USD 2017-01-01 – 2017-12-31: -17037000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 433000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fibrocell Science, Inc. · 2017-12-31 Fibrocell Science, Inc. (edgar:357097) Free cash flow: -17470000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17037000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#325934 Filing: 000162828019003496 Input fundies:CapitalExpenditure: 433000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#330887 Filing: 000162828019003496 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 10.3 million Exact value Exact value: -10300000 USD 2018-01-01 – 2018-12-31: -10300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Fibrocell Science, Inc. · 2018-12-31 Fibrocell Science, Inc. (edgar:357097) Net Income: -10300000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10300000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#327101 Filing: 000162828019003496 The citation records this snapshot. The page link may show a newer release later.	−USD 12.7 million Exact value Exact value: -12700000 USD 2018-01-01 – 2018-12-31: -12700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Fibrocell Science, Inc. · 2018-12-31 Fibrocell Science, Inc. (edgar:357097) Operating Cash Flow: -12700000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12700000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#326358 Filing: 000162828019003496 The citation records this snapshot. The page link may show a newer release later.	USD 164,000 Exact value Exact value: 164000 USD 2018-01-01 – 2018-12-31: 164000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Fibrocell Science, Inc. · 2018-12-31 Fibrocell Science, Inc. (edgar:357097) Capital Expenditure: 164000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 164000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#331096 Filing: 000162828019003496 The citation records this snapshot. The page link may show a newer release later.	−USD 12.86 million Calculation and evidence -12700000 − 164000 USD Exact free cash flow: -12864000 USD 2018-01-01 – 2018-12-31: -12700000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 164000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Fibrocell Science, Inc. · 2018-12-31 Fibrocell Science, Inc. (edgar:357097) Free cash flow: -12864000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T12:30:17Z Snapshot: 88bcaa22966a0c378d4e4d32f11604e177946a2f374eb347964726661f62c9bb Dimensions: Consolidated View: https://fundies.io/companies/edgar/357097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12700000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#326358 Filing: 000162828019003496 Input fundies:CapitalExpenditure: 164000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/357097/000162828019003496/fcsc-20181231.xml#331096 Filing: 000162828019003496 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

128 filings · 2,382 latest values · 2,382 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000357097, 357097, FCSC, edgar:357097, fcsc

Also known as AMERICAN FINANCIAL HOLDING INC /DE, Fibrocell Science, Inc., ISOLAGEN INC

Fibrocell Science, Inc.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2018 2018-01-01 – 2018-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation